High-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome

Ophthalmic Surgery Lasers and Imaging

Volumn 38, Issue 5, 2007, Pages 423-428

  Yoon, Michael K ^a   Chen, Royce W ^a   Hedges III, Thomas R ^a,d   Srinivasan, Vivek J ^b   Gorczynska, Iwona ^a,b   Fujimoto, James G ^b   Wojtkowski, Maciej ^a,b   Schuman, Joel S ^c   Duker, Jay S ^a  

^a TUFTS UNIVERSITY   (United States)

^b Department of Electrical Engineering and Computer Science   (United States)

^c University of Pittsburgh School of Medicine   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUNTER SYNDROME; MALE; NERVE CELL; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA; RETINA FOVEA; VISUAL FIELD DEFECT;

EID: 35848963431     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20070901-14     Document Type: Article

References (13)

1. McDonnell JM, Green WR, Maumenee IH. Ocular histopathology of systemic mucopolysaccharidosis, type II-A (Hunter syndrome, severe). Ophthalmology. 1985;92:1772-1779.
2. Srinivasan V, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:2054. e1-e14.
3. Fujimoto JG, Huang D, Hee MR, et al. Physical properties of optical coherence tomography. In: Schuman JS, Puliafito CA, Fujimoto JG, eds. Optical Coherence Tomography of Ocular Diseases, 2nd ed. Thorofare, NJ: SLACK Incorporated; 2004:677-688.
4. Goldberg MF, Duke JR. Ocular histopathology in Hunter's syndrome: systemic mucopolysaccharideosis type II. Arch Ophthalmol. 1967;77:503-512.
5. Topping TM, Kenyon KR, Goldberg MF, Maumenee AE. Ultrastructural ocular pathology of Hunter's syndrome: systemic mucopolysaccharideosis type II. Arch Ophthalmol. 1971;86:164-177.
6. To K, Adamian M, Dryja TP, Berson EL. Retinal histopathology of an autopsy eye with advanced retinitis pigmentosa in a family with rhodopsin Glu181Lys. Am J Ophthalmol. 2000;130:790-792.
7. Abraham FA, Yatziv S, Russell A, Auerbach E. Electrophysiological and psychophysical findings in Hunter syndrome. Arch Ophthalmol. 1974;91:181-186.
8. Caruso RC, Kaiser-Kupfer MI, Muenzer J, Ludwig IH, Zasloff MA, Mercer PA. Electroretinographic findings in the mucopolysaccharidoses. Ophthalmology. 1986;93:1612-1616.
9. Beck M, Cole G. Disc oedema in association with Hunter's syndrome: ocular histopathological findings. Br J Ophthalmol. 1984;68:590-594.
10. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JSS. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol. 2006;124:193-198.
11. Ko TH, Fujimoto JG, Schuman JS, et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology. 2005;112:1922-1922.e1-e15.
12. Anawis MA. Hunter syndrome (MPS II-B): a report of bilateral vitreous floaters and maculopathy. Ophthalmic Genet. 2006;27:71-72.
13. Muenzer J, Wraith JE, Beck M, et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase therapy in mucopolysaccharidosis II (Hunter syndrome). Genet Med. 2006;8:465-473.